{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"20.21","upperLimit":"38.08","value":"28.25"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"137"}],"units":"Participants"}],"description":"Time from first bb2121 infusion to time of death due to any cause.","dispersionType":"95% Confidence Interval","groups":[{"description":"BB2121","id":"OG000","title":"BB2121"}],"paramType":"MEDIAN","populationDescription":"All Treated Population","reportingStatus":"POSTED","timeFrame":"From screening to the end of follow up (approximately 5 years and 2 months)","title":"Overall Survival","type":"SECONDARY","unitOfMeasure":"Months"}